Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | TYMS | P04818 | 6/20 | 0.55 |
| ▸ | POLA1 | P09884 | 1/20 | 0.55 |
| ▸ | POLD1 | P28340 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6130170 | 0.86 | POLB (0.54) | POLBTYMSPOLA1POLD1 | |
| SCHEMBL2515240 | 0.86 | POLB (0.59) | POLBTYMSPOLA1POLD1 | |
| SCHEMBL14930108 | 0.86 | POLB (0.59) | POLBTYMSPOLA1POLD1 | |
| SCHEMBL10046513 | 0.86 | POLB (0.59) | POLBTYMSPOLA1POLD1 | |
| SCHEMBL30553887 | 0.84 | POLB (0.52) | POLBTYMSPOLA1POLD1 | |
| SCHEMBL4211830 | 0.84 | POLG (0.50) | POLB | |
| Deoxythymidine_Triphosphate SCHEMBL11055949 | 0.84 | POLB (0.78) | POLBTYMSPOLA1POLD1 | |
| SCHEMBL21682516 | 0.84 | POLB (0.78) | POLBTYMSPOLA1POLD1 | |
| Deoxythymidine_Triphosphate SCHEMBL21275938 | 0.84 | POLB (0.78) | POLBTYMSPOLA1POLD1 | |
| Deoxythymidine_Triphosphate SCHEMBL18785124 | 0.84 | POLB (0.78) | POLBTYMSPOLA1POLD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4381093-A1 | METHODS OF DETERMINING THE NUMBER OF COPIES OR SEQUENCE OF ONE OR MORE RNA MOLECULES | Basic Genomics AB (SE) | 2024-06-12 | — | — | EP | claimed |
| CN-117813393-A | Method for determining copy number or sequence of one or more RNA molecules | 基础基因组学公司 | 2024-04-02 | — | — | CN | claimed |
| WO-2023012065-A1 | METHODS OF DETERMINING THE NUMBER OF COPIES OR SEQUENCE OF ONE OR MORE RNA MOLECULES | BASIC GENOMICS AB (SE) | 2023-02-09 | — | — | WO | claimed |
| US-12546784-B2 | Multiplex isotype-specific antibody detection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250129419-A1 | REAGENTS FOR LABELING BIOMOLECULES AND USES THEREOF | ULTIMA GENOMICS INC (US) | 2025-04-24 | — | — | US | disclosed |
| EP-3601604-B1 | MULTIPLEX ISOTYPE-SPECIFIC ANTIBODY DETECTION | UNIV LELAND STANFORD JUNIOR (US) | 2025-02-19 | — | — | EP | disclosed |
| EP-4483172-A2 | REAGENTS FOR LABELING BIOMOLECULES AND USES THEREOF | Ultima Genomics, Inc. (US) | 2025-01-01 | — | — | EP | disclosed |
| US-12173365-B2 | Sequencing using non-natural nucleotides | ULTIMA GENOMICS, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240384261-A1 | METHODS, COMPOSITIONS, AND KITS FOR PREPARING SEQUENCING LIBRARY | GENEFIRST LIMITED (GB) | 2024-11-21 | — | — | US | disclosed |
| US-12054768-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-06 | — | — | US | disclosed |
| EP-4381093-A1 | METHODS OF DETERMINING THE NUMBER OF COPIES OR SEQUENCE OF ONE OR MORE RNA MOLECULES | Basic Genomics AB (SE) | 2024-06-12 | — | — | EP | disclosed |
| US-20210403978-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-12-30 | — | — | US | disclosed |
| US-11149296-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-10-19 | — | — | US | disclosed |
| US-20200309784-A1 | Multiplex Isotype-Specific Antibody Detection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2020-10-01 | — | — | US | disclosed |
| US-20200216889-A1 | SEQUENCING USING NON-NATURAL NUCLEOTIDES | ULTIMA GENOMICS, INC. | 2020-07-09 | — | — | US | disclosed |
| EP-3601604-A1 | MULTIPLEX ISOTYPE-SPECIFIC ANTIBODY DETECTION | The Board of Trustees of the Leland Stanford Junior University (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2018183779-A1 | MULTIPLEX ISOTYPE-SPECIFIC ANTIBODY DETECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-10-04 | — | — | WO | disclosed |
| US-20180100181-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-12 | — | — | US | disclosed |
| EP-3283638-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | The Regents of The University of California (US) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016168711-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12546784-B2 | Multiplex isotype-specific antibody detection | LY96, FCER2, FCGR1A | POLB 121/4885TYMS 4312/4885POLA1 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.